Structure Therapeutics
Filed with the SEC on · accession 0001104659-26-124503
GPCR filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +5.2% by the first close after the filing.
Structure Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results including cash position, operating expenses, and share-based compensation details.
Close before
$20.35
Nov 6, 2026
First close after
+5.21%
$21.41
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GPCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GPCR?
Click hereGPCR filed a 10-Q (SEC filing). Structure Therapeutics filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing routine financial results including cash position, operating expenses, and share-based compensation details.
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
GPCR closed at $20.35 before the filing and $21.41 on Nov 9, 2026 (+5.21%).
Get alerts when GPCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days